We are live on
!
Find out more
Pictet Asset Management Portfolio holdings
AUM
$105B
1-Year Est. Return
38.07%
This Fund
S&P 500
This Quarter
Est. Return
-2.95%
1 Year Est. Return
+38.07%
3 Year Est. Return
+113.98%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$94.8B
AUM Growth
-$8.26B
(-8%)
Cap. Flow
-$2.48B
Cap. Flow
% of AUM
-2.61%
Top 10 Holdings %
Top 10 Hldgs %
21.55%
Holding
2,181
New
100
Increased
1,075
Reduced
690
Closed
79
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
AstraZeneca
AZN
|
+$671M |
| 2 |
Broadcom
AVGO
|
+$416M |
| 3 |
ServiceNow
NOW
|
+$264M |
| 4 |
Arista Networks
ANET
|
+$262M |
| 5 |
Autodesk
ADSK
|
+$235M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Lam Research
LRCX
|
+$284M |
| 2 |
Microsoft
MSFT
|
+$281M |
| 3 |
Micron Technology
MU
|
+$275M |
| 4 |
Teradyne
TER
|
+$274M |
| 5 |
KLA
KLAC
|
+$243M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 34.64% |
| 2 | Industrials | 14.32% |
| 3 | Healthcare | 12.96% |
| 4 | Financials | 7.97% |
| 5 | Utilities | 7.04% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
851
Ocular Therapeutix
OCUL
$2.25B
| $2.71M | ﹤0.01% |
362,596
+335,324
| +1,230% | +$3.2M |
|
852
Generac Holdings
GNRC
$13.1B
| $2.71M | ﹤0.01% |
13,880
-180
| -1% | -$34.6K |
|
853
Tenet Healthcare
THC
$21.5B
| $2.71M | ﹤0.01% |
14,336
+830
| +6% | +$175K |
|
854
Hasbro
HAS
$13.4B
| $2.69M | ﹤0.01% |
28,709
+2,794
| +11% | +$261K |
|
855
Corebridge Financial
CRBG
$15.1B
| $2.67M | ﹤0.01% |
112,104
-60,195
| -35% | -$1.68M |
|
|
CNTA
856
DELISTED
Centessa Pharmaceuticals
CNTA
| $2.67M | ﹤0.01% |
+96,910
| New | +$2.48M |
|
857
TKO Group
TKO
$14.3B
| $2.66M | ﹤0.01% |
13,201
+471
| +4% | +$96.3K |
|
858
RBC Bearings
RBC
$17.6B
| $2.66M | ﹤0.01% |
4,900
+392
| +9% | +$208K |
|
859
Ovintiv
OVV
$17.5B
| $2.66M | ﹤0.01% |
44,827
+5,679
| +15% | +$274K |
|
860
ITT
ITT
$19.4B
| $2.66M | ﹤0.01% |
13,944
+1,133
| +9% | +$216K |
|
861
Stanley Black & Decker
SWK
$15.5B
| $2.61M | ﹤0.01% |
36,785
+1,189
| +3% | +$95.5K |
|
862
Align Technology
ALGN
$12.4B
| $2.61M | ﹤0.01% |
15,243
-230
| -1% | -$40.3K |
|
|
TEM
863
Tempus AI
TEM
$9.85B
| $2.6M | ﹤0.01% |
60,468
+11,980
| +25% | +$681K |
|
864
Erie Indemnity
ERIE
$13.5B
| $2.58M | ﹤0.01% |
10,277
-515
| -5% | -$138K |
|
865
Tarsus Pharmaceuticals
TARS
$3.07B
| $2.57M | ﹤0.01% |
38,198
+620
| +2% | +$43.3K |
|
|
GRAL
866
GRAIL Inc
GRAL
$3.08B
| $2.53M | ﹤0.01% |
53,284
+12,358
| +30% | +$957K |
|
867
Zillow
Z
$7.48B
| $2.52M | ﹤0.01% |
60,863
-1,302
| -2% | -$69.2K |
|
868
MKS Inc
MKSI
$20.7B
| $2.51M | ﹤0.01% |
10,903
+656
| +6% | +$148K |
|
869
CALL
Adobe
ADBE
$103B
| $2.46M | ﹤0.01% |
+10,129
| New | +$2.81M |
|
870
MACOM Technology Solutions
MTSI
$23.7B
| $2.45M | ﹤0.01% |
11,015
+913
| +9% | +$204K |
|
|
PR
871
Permian Resources
PR
$18B
| $2.38M | ﹤0.01% |
111,440
+7,888
| +8% | +$136K |
|
872
Vale
VALE
$61.4B
| $2.36M | ﹤0.01% |
+148,305
| New | +$2.32M |
|
|
SGI
873
Somnigroup International
SGI
$13.5B
| $2.35M | ﹤0.01% |
31,853
+2,995
| +10% | +$260K |
|
874
East-West Bancorp
EWBC
$18.5B
| $2.34M | ﹤0.01% |
21,874
+1,732
| +9% | +$195K |
|
875
Jones Lang LaSalle
JLL
$16.7B
| $2.33M | ﹤0.01% |
7,670
+520
| +7% | +$168K |
|
Similar funds
Pictet Asset Management's Q1 2026 Portfolio in Review
As of Q1 2026, Pictet Asset Management held 2,181 positions worth $94.8B, down 8% from $103B the previous quarter. Its ten largest holdings account for 22% of the portfolio.
Pictet Asset Management's Q1 2026 filing shows 100 new, 1,075 increased, 690 reduced and 79 closed positions. Its largest new stake was AstraZeneca: 3,481,864 shares worth $675M. The largest sale was Lam Research, an estimated $284M.
By sector, the portfolio is most concentrated in Technology at 35% of assets, down from 35% a quarter earlier, followed by Industrials and Healthcare.
- Pictet Asset Management's largest Q1 2026 buy was AstraZeneca: 3,481,864 shares worth $675M.
- Pictet Asset Management added most to Broadcom in Q1 2026, an estimated $416M increase.
- Pictet Asset Management's biggest Q1 2026 reduction was Lam Research, cutting an estimated $284M.
- Pictet Asset Management fully exited CyberArk in Q1 2026, selling an estimated $104M.
- Pictet Asset Management's ten largest holdings make up 22% of its $94.8B portfolio in Q1 2026.
- Pictet Asset Management opened 100 new positions and closed 79 in Q1 2026.
- Pictet Asset Management's portfolio value fell 8% quarter-over-quarter to $94.8B.
Based on Pictet Asset Management's 13F filing for Q1 2026, filed 22 Apr 2026.